3.9 Article

Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response

期刊

MOLECULAR ENDOCRINOLOGY
卷 23, 期 3, 页码 337-348

出版社

OXFORD UNIV PRESS INC
DOI: 10.1210/me.2008-0361

关键词

-

资金

  1. Doris Factor Molecular Endocrinology Laboratory
  2. National Institutes of Health [CA75979]

向作者/读者索取更多资源

Somatostatin (SRIF) binds G protein-coupled SRIF receptor subtypes (SST1, -2, -3, -4, and -5) to regulate cell secretion and proliferation. Hypothalamic SRIF inhibits pituitary growth hormone, thyroid stimulating hormone, and ACTH secretion. We tested SRIF-independent constitutive SST activity in AtT20 mouse pituitary corticotroph cells in which ACTH secretion is highly sensitive to SRIF action. Stable transfectants expressing SST2 or SST5 were sensitized to selective agonist action, and constitutive SST receptor activity was demonstrated by forskolin and pertussis toxin cAMP cell responses. Persistent constitutive SST activity decreased cell ACTH responses to CRH through decreased expression of CRH receptor subtype 1. Decreased dopamine receptor type 1 expression was associated with attenuated dopamine agonist action, whereas responses to isoproterenol were enhanced through increased beta 2-adrenoreceptor expression. Thus, integrated pituitary cell ACTH regulation is determined both by phasic SRIF action, as well as by tonic constitutive SST activity, independently of SRIF. (Molecular Endocrinology 23: 337-348, 2009)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas

Raul M. Luque, Alejandro Ibanez-Costa, Leonardo Vieira Neto, Giselle F. Taboada, Daniel Hormaechea-Agulla, Leandro Kasuki, Eva Venegas-Moreno, Alberto Moreno-Carazo, Maria Angeles Galvez, Alfonso Soto-Moreno, Rhonda D. Kineman, Michael D. Culler, Manuel D. Gahete, Monica R. Gadelha, Justo P. Castano

CANCER LETTERS (2015)

Article Oncology

In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters

Raul M. Luque, Miguel Sampedro-Nunez, Manuel D. Gahete, Ana Ramos-Levi, Alejandro Ibanez-Costa, Esther Rivero-Cortes, Ana Serrano-Somavilla, Magdalena Adrados, Michael D. Culler, Justo P. Castano, Monica Marazuela

ONCOTARGET (2015)

Article Oncology

Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors

Miguel Sampedro-Nunez, Raul M. Luque, Ana M. Ramos-Levi, Manuel D. Gahete, Ana Serrano-Somavilla, Alicia Villa-Osaba, Magdalena Adrados, Alejandro Ibanez-Costa, Elena Martin-Perez, Michael D. Culler, Monica Marazuela, Justo P. Castano

ONCOTARGET (2016)

Article Multidisciplinary Sciences

In 1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features

Alejandro Ibanez-Costa, Manuel D. Gahete, Esther Rivero-Cortes, David Rincon-Fernandez, Richard Nelson, Manuel Beltran, Andres de la Riva, Miguel A. Japon, Eva Venegas-Moreno, Ma Angeles Galvez, Juan A. Garcia-Arnes, Alfonso Soto-Moreno, Jennifer Morgan, Natia Tsomaia, Michael D. Culler, Carlos Dieguez, Justo P. Castano, Raul M. Luque

SCIENTIFIC REPORTS (2015)

Article Oncology

The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients

Manuel D. Gahete, David Rincon-Fernandez, Mario Duran-Prado, Marta Hergueta-Redondo, Alejandro Ibanez-Costa, Alejandro Rojo-Sebastian, Francisco Gracia-Navarro, Michael D. Culler, Oriol Casanovas, Gema Moreno-Bueno, Raul M. Luque, Justo P. Castano

ONCOTARGET (2016)

Article Biochemistry & Molecular Biology

The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer

Daniel Hormaechea-Agulla, Juan M. Jimenez-Vacas, Enrique Gomez-Gomez, Fernando L. - Lopez, Julia Carrasco-Valiente, Jose Valero-Rosa, Maria M. Moreno, Rafael Sanchez-Sanchez, Rosa Ortega-Salas, Francisco Gracia-Navarro, Michael D. Culler, Alejandro Ibanez-Costa, Manuel D. Gahete, Maria J. Requena, Justo P. Castano, Raul M. Luque

FASEB JOURNAL (2017)

Article Biochemistry & Molecular Biology

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness

Daniel Hormaechea-Agulla, Manuel D. Gahete, Juan M. Jimenez-Vacas, Enrique Gomez-Gomez, Alejandro Ibanez-Costa, Fernando L-Lopez, Esther Rivero-Cortes, Andre Sarmento-Cabral, Jose Valero-Rosa, Julia Carrasco-Valiente, Rafael Sanchez-Sanchez, Rosa Ortega-Salas, Maria M. Moreno, Natia Tsomaia, Steve M. Swanson, Michael D. Culler, Maria J. Requena, Justo P. Castano, Raul M. Luque

MOLECULAR CANCER (2017)

Article Genetics & Heredity

Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells

Kristina B. Dossing, Christina Kjaer, Jonas Vikesa, Tina Binderup, Ulrich Knigge, Michael D. Culler, Andreas Kjaer, Birgitte Federspiel, Lennart Friis-Hansen

Article Medicine, Research & Experimental

Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131

Lex Van der Ploeg, Haley Laken, Shubh Sharma, Rakesh Datta, Heather Halem, Jesse Dong, Caroline Touvay, Marc Teillot, Patrick Noonan, Lou Tartaglia, Liz Stoner, Bart Henderson, Keith Gottesdiener, Michael Culler

LIFE SCIENCES (2014)

Article Cell Biology

Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: Effect of mono- and bi-specific somatostatin analogs on cell growth

M. Ruscica, P. Magni, L. Steffani, F. Gatto, M. Albertelli, R. Rametta, L. Valenti, P. Amen, V. Magnaghi, M. D. Culler, F. Minuto, D. Ferone, M. Arvigo

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)

Review Pharmacology & Pharmacy

International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature

Thomas Guenther, Giovanni Tulipano, Pascal Dournaud, Corinne Bousquet, Zsolt Csaba, Hans-Juergen Kreienkamp, Amelie Lupp, Marta Korbonits, Justo P. Castano, Hans-Juergen Wester, Michael Culler, Shlomo Melmed, Stefan Schulz

PHARMACOLOGICAL REVIEWS (2018)

Article Multidisciplinary Sciences

BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas

Alejandro Ibanez-Costa, Laura M. Lopez-Sanchez, Manuel D. Gahete, Esther Rivero-Cortes, Mari C. Vazquez-Borrego, Maria A. Galvez, Andres de la Riva, Eva Venegas-Moreno, Luis Jimenez-Reina, Alberto Moreno-Carazo, Francisco J. Tinahones, Silvia Maraver-Selfa, Miguel A. Japon, Juan A. Garcia-Arnes, Alfonso Soto-Moreno, Susan M. Webb, Rhonda D. Kineman, Michael D. Culler, Justo P. Castano, Raul M. Luque

SCIENTIFIC REPORTS (2017)

Article Oncology

Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors

Aura D. Herrera-Martinez, Rosanna van den Dungen, Fadime Dogan-Oruc, Peter M. van Koetsveld, Michael D. Culler, Wouter W. de Herder, Raul M. Luque, Richard A. Feelders, Leo J. Hofland

ENDOCRINE-RELATED CANCER (2019)

Article Oncology

In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines

David Rincon-Fernandez, Michael D. Culler, Natia Tsomaia, Gema Moreno-Bueno, Raul M. Luque, Manuel D. Gahete, Justo P. Castano

CARCINOGENESIS (2018)

暂无数据